Ceftavia is an injectable antibiotic containing Ceftazidime, a third-generation cephalosporin. What makes Ceftazidime special compared to other antibiotics in its class is its high activity against Pseudomonas aeruginosa, a particularly tough and dangerous type of bacteria often found in hospitals. It is used to treat severe lung infections (especially in cystic fibrosis patients), urinary tract infections, and bloodstream infections (sepsis).

It works by disrupting the bacterial cell wall synthesis. Because it is so effective against Gram-negative bacteria, it is a staple in hospital pharmacies. It is usually administered every 8 to 12 hours. Like other cephalosporins, it is generally safe but can occasionally cause allergic reactions or digestive issues. It is important for the medical team to monitor the patient’s kidney function, as the dose may need to be lowered if the kidneys are not clearing the medicine quickly enough.